Xu, Hua-Xiang <br/><br/>
Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection.  [electronic resource] 

 -  European journal of nuclear medicine and molecular imaging  Jun 2014 
 - 1093-102 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1619-7089 
<br/><br/><label>Standard No.: </label>10.1007/s00259-014-2688-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antigens, Tumor-Associated, Carbohydrate--blood<br/>Carcinoma, Pancreatic Ductal--diagnostic imaging<br/>Female<br/>Fluorodeoxyglucose F18<br/>Humans<br/>Male<br/>Middle Aged<br/>Multimodal Imaging<br/>Pancreatic Neoplasms--diagnostic imaging<br/>Positron-Emission Tomography<br/>Postoperative Period<br/>Radiopharmaceuticals<br/>Tomography, X-Ray Computed<br/>Treatment Outcome<br/>Tumor Burden